when will eli lilly release retatrutide Who Makes Retatrutide? Company Behind the Weight Loss Drug retatrutide expanded access program eli

Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials

02See Symptoms Beside Doses, So Timing Patterns Show Up The question behind a changed period, new hot flashes, or deeper fatigue is almost always the same: is this the medication, the weight change, or something else

[2] [3] GLP-1 medications reduced major adverse cardiovascular events by 20% in the SELECT trial, with benefits extending beyond weight loss alone

What to expect at each dose level 1mg (weeks 1-4): Mild to moderate nausea in 15-25% of users